StreetAlpha.app
Home › Stocks › HCAT

Health Catalyst, Inc. (HCAT)

Healthcare
$1.31
▲ +1.55%
LAST CLOSE · NOV 20

Health Catalyst provides data and analytics technology and services to healthcare providers from South Jordan, Utah. It last closed at $1.31 on Nov 20, up 1.55% on the day. The next earnings report for HCAT is expected around Mon, Jan 11, 2027, after the close. For the quarter ended Sep 2026, HCAT reported EPS of $0.53 on revenue of $56.3M, with revenue down 26.3% from a year ago. Over its last 8 reports the stock moved an average of 12.2% the session after earnings. Over the last 12 months HCAT insiders bought $105K of stock on the open market and sold $342K, according to SEC Form 4 filings.

AI Auto Pilots
Is HCAT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold HCAT.

Key Stats

Last 12 months
Results
Revenue
$272.2M
−13.9% vs a year ago
Net income
−$202.1M
−74.2% margin
EPS (diluted)
−$2.80
Free cash flow
$25.7M
9.4% margin
Valuation
Market cap
$99.8M
76.2M shares
P/E
–
No P/E while losing money
Price to sales
0.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$53.7M
At Sep 30
Debt
$0
At Sep 30
Shareholder equity
$145.6M
Shares outstanding
76.2M
At Nov 2
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $241.9M$241.9MFY2021FY2022: $276.2M$276.2MFY2022FY2023: $295.9M$295.9MFY2023FY2024: $306.6M$306.6MFY2024FY2025: $311.1M$311.1MFY2025

From HCAT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Jan 11
Estimated date · After the close
Reported EPS
$0.53
Quarter ended Sep 2026
Year ago EPS
-$0.32
Same quarter last year
Revenue
$56.3M
−26.3% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.33Dec '24Mar 2025: -$0.35Mar '25Jun 2025: -$0.59Jun '25Sep 2025: -$0.32Sep '25Dec 2025: -$1.30Dec '25Mar 2026: -$1.53Mar '26Jun 2026: -$0.55Jun '26Sep 2026: $0.53Sep '26Latest $0.53
Revenue by quarter
Dec 2024: $79.6MDec '24Mar 2025: $79.4MMar '25Jun 2025: $80.7MJun '25Sep 2025: $76.3MSep '25Dec 2025: $74.7MDec '25Mar 2026: $70.8MMar '26Jun 2026: $70.5MJun '26Sep 2026: $56.3MSep '26Latest $56.3M
How HCAT moved after its last 8 reports
Average move the session after a report ±12.2%
Nov 5, 2026After the close−2.7%
Aug 6, 2026After the close−25.1%
May 11, 2026After the close+7.3%
Mar 12, 2026After the close−26.3%
Jan 12, 2026After the close−2.4%
Nov 10, 2025After the close−5.6%
Aug 7, 2025After the close−23.3%
May 7, 2025After the close+5.3%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on HCATStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on HCAT
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on HCAT

Technical Analysis

HCAT · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold

The stock is 14% below its 20 day and 26% below its 50 day average. It is 26% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 37), near oversold. The nearest support is the swing low (Jun 3) at $1.28, and the nearest resistance the Pivot at $1.32.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 9.2%/day
Key levels
$3.0252 week high+130.5%
$1.80100 day average+37.4%
$1.66200 day average+26.7%
$1.6550 day average+26.0%
$1.5020 day average+14.5%
$1.46Swing high (May 28)+11.5%
$1.37Pivot R1+4.6%
$1.32Pivot+0.8%
$1.31Last close
$1.28Swing low (Jun 3)−2.3%
$1.26Pivot S1−3.8%
$0.9652 week low−26.7%
Indicators
RSI (14)37.24Weak, oversold below 30Neutral
MACD-0.10Below its signal lineBearish
Stochastic6.5Near the bottom of its rangeOversold
ADX (14)19.6No clear trend
Williams %R-88.1Oversold below −80, overbought above −20Oversold
CCI (20)-107.1Oversold below −100, overbought above 100Oversold
Rate of change−10.3%Change over 10 sessionsBearish
ATR (14)$0.12Typical daily range, 9.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for HCAT

What happened before

See how HCAT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow HCAT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How HCAT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for HCATHow many large options trades hit HCAT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

HCAT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼37 buying vs 77 selling
  • ▼Held by funds -2.4 pts
  • ▼Funds holding -20
  • ▼Superinvestors: 1 added, 3 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding110130−15.4%
In funds' top 10220.0%
Held by funds66.9%69.3%−2.4 pts
New / increased13 / 2434 / 33−44.8%
Reduced / sold out45 / 3243 / 35−1.3%
Put/call ratio0.380.380.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See HCAT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

HCAT Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$105K1 buy · 1 insider
Sold$342K3 sales · 2 insiders
62% of the selling was under pre-arranged trading plans.
2025-12 sold $201K2026-09 bought $105K2026-11 sold $141KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 12Benjamin LandryGeneral CounselSale plan99,478$1.42$141K
Sep 14Simeon KohlCEOBuy59,000$1.79$105K
Dec 5, 2025Benjamin LandryGeneral CounselSale plan27,425$2.64$72K
Dec 4, 2025Julie Larson-GreenDirectorSale47,997$2.67$128K
Sep 5, 2025Benjamin LandryGeneral CounselSale plan6,175$3.35$21K
Jun 5, 2025Benjamin LandryGeneral CounselSale plan6,057$3.94$24K
Every insider buy and sale for HCAT over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See HCAT insider trades →

From SEC Form 4 filings by HCAT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HCAT is in one of them and how their past HCAT trades turned out.

HCAT in the AI portfolios
Loading…

HCAT News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered HCAT in an article yet. Here's the latest on the wider market.

HCAT in the news

About Health Catalyst

Health Catalyst is a data and analytics company based in South Jordan, Utah. It sells Ignite, a data and analytics platform delivered through the cloud, along with software applications that help organizations find ways to improve clinical, financial, and operational performance. It also offers consulting, implementation, education, and managed services. Its customers are primarily healthcare providers.

Headquarters
South Jordan, UT